Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
41.99 226.12 54.38 42.17 43.80 35.72 28.03 33.70 14.79 33.68
P/S ratio
2.77 3.73 4.16 4.81 5.61 5.80 4.40 4.77 4.69 4.92
P/FCF ratio
27.70 23.07 25.92 34.14 33.91 28.89 24.61 37.78 30.99 29.50
P/Operating CF
49.30 62.37 72.04 63.56 51.11 81.45 82.59 62.92 68.62 65.80
P/B ratio
2.78 3.29 4.14 4.91 5.88 6.93 5.21 4.92 4.11 4.13
EV/Sales
2.86 4.40 4.66 5.25 5.94 5.98 4.55 4.95 4.84 5.01
EV/EBITDA
13.11 21.90 20.47 22.18 23.67 21.53 17.09 20.42 20.21 19.89
EV/FCF
28.62 27.15 29.03 37.21 35.90 29.79 25.46 39.24 31.96 30.04
Current Ratio
4.02 2.26 1.62 1.44 1.72 1.85 1.63 1.64 1.67 1.58
Net Debt/EBITDA
0.42 3.29 2.20 1.83 1.31 0.65 0.57 0.76 0.61 0.36
Debt/Equity
1.00 0.89 0.63 0.57 0.56 0.50 0.45 0.38 0.29 0.25
ROE
6.66% 1.84% 7.66% 11.89% 13.98% 20.49% 19.01% 15.11% 30.91% 12.96%
ROA
2.98% 0.74% 3.30% 5.46% 6.40% 9.57% 9.27% 7.75% 17.33% 7.76%
ROIC
8.36% 1.99% 4.96% 6.28% 7.54% 12.02% 12.01% 8.76% 7.89% 8.87%
Return on Tangible Assets
5.42% 2.53% 17.96% 28.71% 25.59% 35.19% 36.69% 30.15% 66.49% 30.61%
Average Days of Receivables
56.85 69.95 61.86 62.07 67.65 54.97 51.99 59.74 60.25 65.29
Earnings Yield
2.38% 0.44% 1.84% 2.37% 2.28% 2.80% 3.57% 2.97% 6.76% 2.97%
Free Cash Flow Yield
3.61% 4.34% 3.86% 2.93% 2.95% 3.46% 4.06% 2.65% 3.23% 3.39%
Free Cash Flow per Share
1.41 2.55 2.79 2.54 3.23 4.87 4.45 2.91 3.65 4.25
Book value per Share
14.03 17.87 17.48 17.70 18.61 20.30 21.05 22.31 27.53 30.31
Free Cash Flow
2,082.00 4,435.00 4,906.00 4,498.00 5,724.00 8,648.00 7,804.00 5,059.00 6,351.00 7,395.00
EV/EBIT
19.69 76.98 39.02 36.93 38.36 30.58 23.76 30.65 29.74 27.58
Other line items

Show all line items

Columns are period end dates